ZORVOLEX®: The lowest FDA-approved dose of diclofenac available (18 mg)
ZORVOLEX is a nonsteroidal anti-inflammatory drug (NSAID) for patients with mild to moderate acute pain or osteoarthritis pain. Iroko Pharmaceuticals, LLC developed ZORVOLEX to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.
Do you know your NSAID dose?
Ask your doctor if you are taking the lowest dose possible for the treatment of mild to moderate acute pain or OA pain. Then ask about ZORVOLEX, the low-dose SoluMatrix® diclofenac from Iroko.
ZORVOLEX®: Possible side effects
Before beginning treatment with ZORVOLEX, it is important to be aware of potential side effects and to discuss these potential problems with your doctor
- In clinical studies, the most common side effects reported with ZORVOLEX were swelling, nausea, headache, dizziness, vomiting, constipation, itching, diarrhea, gas, leg or foot pain, abdominal pain, stuffy or runny nose, abnormal blood tests, high blood pressure, and heartburn
ZORVOLEX®: Dosing and administration
ZORVOLEX is FDA-approved at low, 18-mg and 35-mg doses administered 3 times daily:
- In clinical studies, patients taking ZORVOLEX had greater reductions in osteoarthritis pain and mild to moderate acute pain compared with patients who took placebo
- ZORVOLEX can be used for management of mild to moderate acute pain at low doses of 18 mg and 35 mg 3 times daily
- ZORVOLEX can be used for management of osteoarthritis pain at a dose of 35 mg 3 times daily